Galien Forum Logo
weeks
+
days
Galien_Forum USA 2025 logo in white

To “celebrate” biomedical research as the substrate to this great life science industry. 

Thursday Oct. 30, 2025

7:30 AM - 5 PM
ALEXANDRIA CENTER FOR LIFE SCIENCES,
NEW YORK CITY

Register for the 2025 Edition
Revisit the 2024 Edition

900

C-LEVEL PARTICIPANTS

120

COMPANIES

80

INSTITUTIONS/
ACADEMICS

* Based on 2024

Galien Forum
Galien Forum Logo
Galien Forum Logo

Thursday Oct. 26, 2023

Science Meets Society:

Balancing Innovation, Equity and Public Health in a Post-Covid World

Read the abstract
Mask Group 163

The Galien Forum, hosted each fall at New York’s Alexandria Center for Life Sciences, provides an entire day of lively discussions featuring Nobel Laureates, prominent policymakers, and top industry leaders who share insights on the most pressing health issues of our era, while showcasing the newest research and clinical approaches to diagnosis, treatment, and cure.

For the first time, in tandem with the Forum, the inaugural Galien Patient Summit will bring together patient groups, key thought leaders, regulators and industry to evaluate challenges through the patient prism.

Don’t miss the debates!

Galien forum press conference hall with peoples

In the program Galien Forum 2023

Thursday Oct. 26, 2023

Preliminary Program

PANEL 1

Promise & Reality:
Decoding AI’s Impact on Drug Development

PANEL 2

Advancing the Pipeline: Ensuring Academic and Government Discoveries are Translated for Medical Impact

PANEL 3

Therapeutic Area Advances and Challenges (mRNA & CRISPR): Getting Gene Therapy Innovation to a Critical Mass of Patients

PANEL 4

Advancing Brain Health: Innovations and Insights for a Healthier Future

PANEL 5

CEO Panel: Courage to Innovate

PANEL 6

How to Build a Paradigm-Transforming Blockbuster?

Galien Forum Logo
PANEL 1
Promise & Reality:
Decoding AI’s Impact on Drug Development
Galien Forum Logo

PANEL 2 
Advancing the Pipeline:
Ensuring Academic and Government Discoveries are Translated for Medical Impact

Mental Health in America
PANEL 3 
Therapeutic Area Advances and Challenges (mRNA & CRISPR): Getting Gene Therapy Innovation to a Critical Mass of Patients
Fireside with J&J’s Alex Gorsky
FIRESIDE CHAT 
Fireside Chat with Alex Gorsky
AI, Digital Health and Clinical Trials

PANEL 4a 
AI's Impact on Personal and Public Health -- Now & in the Future

PANEL OBESITY SCIENCE (1)

PANEL 4b 
Advancing Brain Health: Innovations and Insights for a Healthier Future

Fireside with J&J’s Alex Gorsky
CEO PANEL

How to Build a Paradigm-Transforming Blockbuster

Who will be speaking in 2025

Partial list as of June 24, 2025

Ron Alfa

Ron Alfa

Co-Founder & CEO, NOETIK.ai
Claude Bertrand

Claude Bertrand

Executive Vice President R&D , Chief Scientific Officer, Servier
Albert Bourla Photo

Albert Bourla

Chairman & CEO, Pfizer
Andrea Ciucci Image

Andrea Ciucci, Reverend

Secretary General of the RenAIssance Foundation, The Pontifical Academy for Life, Vatican

Robert M. Davis-1 Image

Robert M. Davis

Chairman and CEO, Merck & Co., Inc
Mikael Dolsten-3

Mikael Dolsten

Former Chief Scientific Officer and President, Worldwide Research, Development and Medical, Pfizer
Cedric Francois (Apellis)-1

Cedric Francois

CEO, Apellis

⁠Kenneth C. Frazier Image

⁠Kenneth C. Frazier

Prix Galien Awards Committee Chair

Categories: Best Medical Technology - Best Digital Solution - Best Incubator / Accelerator / Equity - Best StartUp

Julie Gerberding

Julie Gerberding

President & CEO, Foundation for NIH
Angela Hwang

Angela Hwang

CEO Metaphore Biotechnologies and CEO-Partner Flagship Pioneering
Pratap

Pratap Khedkar

CEO, ZS
 
Julie Kim

Julie Kim

President, U.S. Business Unit, U.S. Country Head & Incoming CEO, Takeda
President Sally Kornbluth

Sally Kornbluth

Pesident, MIT 
Frank D. Lee (Pacira Biosciences)-1

Frank D. Lee

Chief Executive Officer & Director, Pacira Biosciences

Judy Lieberman2

Judy Lieberman

Endowed Chair in Cellular & Molecular Medicine, Program in Cellular and Molecular Medicine, Boston Children’s Hospital

Rob Lin

Rob Lin

CEO, Avista Therapeutics
Michelle Longmire-2

Michelle Longmire

Co-Founder and CEO  Medable, Inc.
Joel Marcus Image

Joel S. Marcus

Executive Chairman and Founder, Alexandria Real Estate Equities, Inc./Alexandria Venture Investments

Thomas Miller_AI

Thomas Miller

Co-founder and CEO, Iambic Therapeutics
Steven Paul

Steven Paul

Founder and Board Chair at Seaport Therapeutics & Venture Partner at Third Rock Ventures
John C. Reed Photo

John C. Reed

Executive Vice President, Innovative Medicine R&D, Johnson & Johnson

Michael Rosenblatt Photo

Michael Rosenblatt, MD

Co-Chair, Galien Forum; Advisory Partner, Ascenta Capital; Senior Advisor, Bain Capital Life Sciences & Flagship Pioneering; Member, Harvard Board of Overseers

⁠Thomas Schinecker Photo

Thomas Schinecker

Chief Executive Officer, Roche Group

Dan Skovronsky

Dan Skovronsky
President, Lilly Research Laboratories and Chief Scientific Officer, Eli Lilly and Company

devyn smith

Devyn Smith

CEO, Arbor Biotechnologies
⁠Marc Tessier-Lavigne Photo

Marc Tessier-Lavigne

President Emeritus and Professor, Stanford University, Stanford, CA

⁠George Yancopoulos Photo

⁠George Yancopoulos

Board co-chair, co-founder, President, and Chief Scientific Officer, Regeneron

Marinka Zitnik

Marinka Zitnik

Associate Professor, Harvard Dept. of Biomedical Informatics & Kempner Institute
Lynne Zydowsky Headshot

Lynne Zydowsky

Chief of Science, Alexandria Real Estate Equities, Inc./Alexandria Venture Investments
See who spoke in the 2022 edition
Register for the 2023 edition
Group 705

TOP SCIENTISTS & KOL

Interested in seeing who has spoken at our events? Check out our impressive roster of Top Scientists and Key Opinion Leaders.

PAST SPEAKERS
Group 721

PREVIOUS DEBATES

Watch continuous debates on the biggest challenges facing human health worldwide

WATCH THE DEBATES